Page 1928 - Williams Hematology ( PDFDrive )
P. 1928

1902  Part XII:  Hemostasis and Thrombosis   Chapter 112:  Platelet Morphology, Biochemistry, and Function           1903




                    1129.  Jamieson GA: The activation of platelets by thrombin: A model for activation by high     1163.  Jones CI, et al: Platelet endothelial cell adhesion molecule-1 inhibits platelet response
                     and moderate affinity receptor pathways. Prog Clin Biol Res 283:137–158, 1988.  to thrombin and von Willebrand factor by regulating the internalization of glycopro-
                    1130.  Ruggeri Z: The platelet glycoprotein Ib-IX complex. Prog Hemost Thromb 10:35–68,   tein  Ib via  AKT/glycogen  synthase  kinase-3/dynamin and  integrin  alphaIIbbeta3.
                     1991.                                                  Arterioscler Thromb Vasc Biol 34(9):1968–1976, 2014.
                    1131.  Katagiri Y, et al: Localization of von Willebrand factor and thrombin-interactive     1164.  Albelda SM, et al: Molecular and cellular properties of PECAM-1 (endoCAM/CD31):
                     domains in human platelet glycoprotein Ib. Thromb Haemost 63:122–126, 1990.  A novel vascular cell-cell adhesion molecule. J Cell Biol 114(5):1059–1068, 1991.
                    1132.  Zarpellon A, et al: Binding of alpha-thrombin to surface-anchored platelet glycopro-    1165.  DeLisser HM, et al: Platelet/endothelial cell adhesion molecule-1 (CD31)-medi-
                     tein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. Proc   ated  cellular  aggregation  involves  cell  surface  glycosaminoglycans.  J Biol Chem
                     Natl Acad Sci U S A 108(21):8628–8633, 2011.           268(21):16037–16046, 1993.
                    1133.  Harmon JT, Jamieson GA: The glycocalicin portion of platelet glycoprotein Ib expresses     1166.  Washington AV, et al: A TREM family member, TLT-1, is found exclusively in the
                     both high and moderate affinity receptor sites of thrombin. A soluble radioreceptor   alpha-granules of megakaryocytes and platelets. Blood 104(4):1042–1047, 2004.
                     assay for the injection of thrombin with platelets. J Biol Chem 261:13224–13229, 1986.    1167.  Kahn ML, Platelet-collagen responses: Molecular basis and therapeutic promise.
                    1134.  Shrimpton CN, et al: Localization of the adhesion receptor glycoprotein Ib-IX-V com-  Semin Thromb Hemost 30(4):419–425, 2004.
                     plex to lipid rafts is required for platelet adhesion and activation. J Exp Med Medicine     1168.  Moroi M, Jung SM: Platelet glycoprotein VI: Its structure and function. Thromb Res
                     (Baltimore) 196(8):1057–1066, 2002.                    114(4):221–233, 2004.
                    1135.  Adam F, et al: Thrombin-induced platelet PAR4 activation: Role of glycoprotein Ib     1169.  Schulz C, et al: EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions
                     and ADP. J Thromb Haemost 1(4):798–804, 2003.          in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost
                    1136.  De Candia E, et al: Binding of thrombin to glycoprotein Ib accelerates the hydrolysis   9(5):1007–1019, 2011.
                     of Par-1 on intact platelets. J Biol Chem 276(7):4692–4698, 2001.    1170.  Arthur JF, et al: Platelet receptor redox regulation. Platelets 19(1):1–8, 2008.
                    1137.  Frenette PS, et al: Platelet-endothelial interactions in inflamed mesenteric venules.     1171.  Jung SM, et al: Constitutive dimerization of glycoprotein VI (GPVI) in resting plate-
                     Blood 91(4):1318–1325, 1998.                           lets is essential for binding to collagen and activation in flowing blood. J Biol Chem
                    1138.  Frenette PS, et al: P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on plate-  287(35):30000–30013, 2012.
                     lets and can mediate platelet-endothelial interactions  in vivo.  J Exp Med 191(8):     1172.  Matus V, et al: An adenine insertion in exon 6 of human GP6 generates a truncated
                     1413–1422, 2000.                                       protein associated with a bleeding disorder in four Chilean families. J Thromb Hae-
                    1139.  Bradford HN, et al: Human kininogens regulate thrombin binding to platelets through   most 11(9):1751–1759, 2013.
                     the glycoprotein Ib-IX-V complex. Blood 90(4):1508–1515, 1997.    1173.  Arthur JF, Dunkley S, Andrews RK: Platelet glycoprotein VI-related clinical defects.
                    1140.  Bradford HN, Pixley RA, Colman RW: Human factor XII binding to the glycopro-  Br J Haematol 139(3):363–372, 2007.
                     tein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem     1174.  Dumont B, et al: Absence of collagen-induced platelet activation caused by compound
                     275(30):22756–22763, 2000.                             heterozygous GPVI mutations. Blood 114(9):1900–1903, 2009.
                    1141.  Baglia FA, et al: Factor XI binding to the platelet glycoprotein Ib-IX-V complex pro-    1175.  Hermans C, et al: A compound heterozygous mutation in glycoprotein VI in a patient
                     motes factor XI activation by thrombin. J Biol Chem 277(3):1662–1668, 2002.  with a bleeding disorder. J Thromb Haemost 7(8):1356–1363, 2009.
                    1142.  Simon DI, et al: Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integ-    1176.  Nurden P, et al: An acquired inhibitor to the GPVI platelet collagen receptor in a
                     rin Mac-1 (CD11b/CD18). J Exp Med 192(2):193–204, 2000.  patient with lupus nephritis. J Thromb Haemost 7(9):1541–1549, 2009.
                    1143.  Corken A, et al: Platelet glycoprotein Ib-IX as a regulator of systemic inflammation.     1177.  Ezumi Y, Uchiyama T, Takayama H, Molecular cloning, genomic structure, chromo-
                     Arterioscler Thromb Vasc Biol 34(5):996–1001, 2014.    somal localization, and alternative splice forms of the platelet collagen receptor glyco-
                    1144.  Yin H, et al: Role for platelet glycoprotein Ib-IX and effects of its inhibition in endo-  protein VI. Biochem Biophys Res Commun 277(1):27–36, 2000.
                     toxemia-induced thrombosis, thrombocytopenia, and mortality. Arterioscler Thromb     1178.  Kotulicova D, et al: Variability of GP6 gene in patients with sticky platelet syndrome
                     Vasc Biol 33(11):2529–2537, 2013.                      and deep venous thrombosis and/or pulmonary embolism. Blood Coagul Fibrinolysis
                    1145.  Jain S, et al: Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc   23(6):543–547, 2012.
                     Natl Acad Sci U S A 104(21):9024–9028, 2007.         1179.  Gibbins  J,  et  al:  Tyrosine  phosphorylation  of  the  Fc  receptor  gamma-chain  in
                    1146.  Mo X, et al: Transmembrane domains are critical to the interaction between platelet   collagen- stimulated platelets. J Biol Chem 271(30):18095–18099, 1996.
                     glycoprotein V and glycoprotein Ib-IX complex. J Thromb Haemost 10(9):1875–1886,     1180.  Tsuji M, et al: A novel association of Fc receptor gamma-chain with glycoprotein
                     2012.                                                  VI and their co-expression as a collagen receptor in human platelets. J Biol Chem
                    1147.  Modderman PW, et al: Glycoproteins V and Ib-IX form a noncovalent complex in the   272(38):23528–23531, 1997.
                     platelet membrane. J Biol Chem 267:364–369, 1992.    1181.  Chacko GW, et al: Clustering of the platelet Fc gamma receptor induces noncovalent
                    1148.  Dong JF, Gao S, Lopez JA: Synthesis, assembly, and intracellular transport of the plate-  association with the tyrosine kinase p72syk. J Biol Chem 269(51):32435–32440, 1994.
                     let glycoprotein Ib-IX-V complex. J Biol Chem 273(47):31449–31454, 1998.    1182.  Qiu WQ, et al: Organization of the human and mouse low-affinity Fc gamma R genes:
                    1149.  McGowan EB, Ding A, Detwiler TC: Correlation of thrombin-induced glycoprotein V   Duplication and recombination. Science 248(4956):732–735, 1990.
                     hydrolysis and platelet activation. J Biol Chem 258:11243.    1183.  Boylan B, et al: Identification of FcgammaRIIa as the ITAM-bearing receptor
                    1150.  Ramakrishnan V, et al: Increased thrombin responsiveness in platelets from mice   mediating alphaIIbbeta3 outside-in  integrin signaling in human  platelets.  Blood
                     lacking glycoprotein V. Proc Natl Acad Sci U S A 1999;96(23):13336–13341, 1983.  112(7):2780–2786, 2008.
                    1151.  Ramakrishnan V, et al: A thrombin receptor function for platelet glycoprotein Ib-IX     1184.  Zhi H, et al: Cooperative integrin/ITAM signaling in platelets enhances thrombus
                     unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci U S A 98(4):1823–1828, 2001.  formation in vitro and in vivo. Blood 121(10):1858–1867, 2013.
                    1152.  Jones CI, Moraes LA, Gibbins JM: Regulation of platelet biology by platelet endothe-    1185.  Yeung J, et al: Platelet 12-LOX is essential for FcgammaRIIa-mediated platelet activa-
                     lial cell adhesion molecule-1. Platelets 23(5):331–335, 2012.  tion. Blood 124(14):2271–2279, 2014.
                    1153.  Newman PJ, et al: PECAM-1 (CD31) cloning and relation to adhesion molecules of     1186.  Berlacher MD, et al: FcgammaRIIa ligation induces platelet hypersensitivity to throm-
                     the immunoglobulin gene superfamily. Science 247:1219–1222, 1990.  botic stimuli. Am J Pathol 182(1):244–254, 2013.
                    1154.  Novinska MS, et al: PECAM-1, in Platelets, edited by AD Michelson, pp 221–230.     1187.  Rosenfeld SI, et al: Human platelet Fc receptor for immunoglobulin G. Identification
                     Academic Press, San Diego, 2002.                       as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest
                    1155.  Privratsky JR, Newman DK, Newman PJ: PECAM-1: Conflicts of interest in inflam-  76(6):2317–2322, 1985.
                     mation. Life Sci 87(3–4):69–82, 2010.                1188.  Rosenfeld SI, et al: Human Fc gamma receptors: Stable inter-donor variation in
                    1156.  Metzelaar MJ, et al: Biochemical characterization of PECAM-1 (CD31 antigen) on   quantitative expression on platelets correlates with functional responses. J Immunol
                     human platelets. Thromb Haemost 66(6):700–707, 1991.   138(9):2869–2873, 1987.
                    1157.  Paddock C, et al: Residues within a lipid-associated segment of the PECAM-1 cyto-    1189.  Anderson GP JG. van de Winkel, Anderson CL: Anti-GPIIb/IIIa (CD41) monoclonal
                     plasmic domain are susceptible to inducible, sequential phosphorylation.  Blood   antibody-induced platelet activation requires Fc receptor-dependent cell-cell interac-
                     117(22):6012–6023, 2011.                               tion. Br J Haematol 79(1):75–83, 1991.
                    1158.  Jackson DE, et al: The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial     1190.  Gratacap MP, et al: Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation
                     cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex dur-  of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activa-
                     ing platelet aggregation. Evidence for a mechanistic link between PECAM-1- and     tion of human platelets. J Biol Chem 273(38):24314–24321, 1998.
                     integrin-mediated cellular signaling. J Biol Chem 272(11):6986–6993, 1997.    1191.  Hildreth JE, Derr D,  Azorsa DO: Characterization  of a novel  self-associating
                    1159.  Crockett J, Newman DK, Newman PJ: PECAM-1 functions as a negative regulator of   Mr 40,000 platelet glycoprotein. Blood 77(1):121–132, 1991.
                     laminin-induced platelet activation. J Thromb Haemost 8(7):1584–1593, 2010.    1192.  Nazi I, Arnold DM, Smith JW, et al: FcgammaRIIa proteolysis as a diagnos-
                    1160.  Jones CI, et al: PECAM-1 expression and activity negatively regulate multiple platelet   tic biomarker for heparin-induced thrombocytopenia.  J Thromb Haemost 11(6):
                     signaling pathways. FEBS Lett 583(22):3618–3624, 2009.  1146–1153, 2013.
                    1161.  Varon D, et al: Platelet/endothelial cell adhesion molecule-1 serves as a costimula-    1193.  Nazi I, et al: The association between platelet activation and FcgammaRIIa proteolysis.
                     tory agonist receptor that modulates integrin-dependent adhesion and aggregation of   J Thromb Haemost 9(4):885–887, 2011.
                     human platelets. Blood 91(2):500–507, 1998.          1194.  Peerschke EI, Ghebrehiwet B: C1q augments platelet activation in response to aggre-
                    1162.  Wee JL, Jackson DE: The Ig-ITIM superfamily member PECAM-1 regulates the   gated Ig. J Immunol 159(11):5594–5598, 1997.
                     “outside-in” signaling properties of integrin alpha(IIb)beta3 in platelets.  Blood     1195.  Boilard E, et al: Influenza virus H1N1 activates platelets through FcgammaRIIA sig-
                     106(12):3816–3823, 2005.                               naling and thrombin generation. Blood 123(18):2854–2863, 2014.







          Kaushansky_chapter 112_p1829-1914.indd   1903                                                                 17/09/15   3:30 pm
   1923   1924   1925   1926   1927   1928   1929   1930   1931   1932   1933